Zanubrutinib
Update Venetoclax in CLL
Acalabrutinib
Obinutuzumab
NCCN Guidelines for Patients for CLL
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic
Cancer.gov
NCCN Guidelines for Patients